ASX companies are rethinking their US playbook with tariffs, policy shifts and supply chain risks pushing more to manufacture onshore.
Eden Innovations, EZZ and AML3D are already there, building resilience, speed and closer customer ties. #ASX
https://t.co/Jrrc8x86Qr
We’re thrilled to welcome Mr Gary Liu as our Non-Executive Chair, bringing his APAC capital markets and listed company expertise to fuel EZZ’s global growth👏🏻 Read more: https://t.co/EG8EqeC1R7
$EZZ 's former Chair Glenn Cross is moving to Chief Strategy Officer. 40+ years in life sciences, Glenn will help EZZ deliver on its strategic priorities.
Read more: https://t.co/i75JAkZ75B
$EZZ is thrilled to be back at the 2025 China International Import Expo (@ciieonline) this week, our 6th consecutive year at this key global trade event! 🎉 Excited to connect with partners, friends and consumers.
ASX Health Quarterly Wrap: with @RaceOncology @EZZLifeScience@NeurotechInt showing progress on multiple fronts, with a strong start to FY26 https://t.co/g6YO2vK7rc #ASX#Health $RAC $EZZ $NTI
Australia’s ageing neighbours are driving a booming “silver economy.” $EZZ is well positioned in healthy ageing and longevity solutions across Asia where demand is accelerating fast. https://t.co/oI13ViBsnX
The US$2T US wellness market is booming.
ASX-listed @EZZLifeScience is jumping in with EZZDAY, its US brand of science-backed, FDA-approved supplements made for America’s wellness craze: https://t.co/IA99IY6fem #ASX#Health $EZZ
$EZZ is pleased to release its Appendix 4C for the quarter ending 30 June 2025. Customer receipts were $21.3m, up 46% on the previous quarter. The company generated $1.4m in positive cash flow and ended the quarter with $20.8m in cash. $EZZ.ax READ MORE: https://t.co/kBIaXD9t0W
$EZZ has entered into a research services agreement with the University of Sydney on a two-year study into a novel multi-ingredient supplement for bone growth. More here: https://t.co/BHnk1j7xka
$EZZ Chair Glenn Cross shares an update on the recently signed a distribution agreement with ROFA Enterprises for the introduction of the EZZ brand into Southeast Asia, with a minimum purchase commitment of $21 million over three years. $EZZ.ax #ASX200#AusBiz
Tina Sun, EZZ’s Global Marketing Head, shares insights on the Company's US launch and the four new products under the #EZZDAY brand — from FDA compliance to supplier selection. $EZZ $EZZ.ax
Join $EZZ Life Science Holdings Chair Glenn Cross for @sharecafetweets upcoming Sip and Learn webinar on 19 June. EZZ will provide an update on its international expansion and strategic progress.
Register for free: https://t.co/lXxnyApbki